ANXA10 and cancer: Within FAP cases, ANXA10 does not differ in cancer-normal but is upregulated in adenoma-normal (FC 2.3, FDR 0.30) and downregulated in cancer-adenoma (FC −1.5, FDR < 0.10) comparisons.